Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
暂无分享,去创建一个
[1] J. Mitchison. Cell Biology , 1964, Nature.
[2] J. Mussini,et al. [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.
[3] AC Tose. Cell , 1993, Cell.
[4] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[5] A. Iwama,et al. The murine stk gene product, a transmembrane protein tyrosine kinase, is a receptor for macrophage-stimulating protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[6] F. Chisari,et al. Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.
[7] M. Karin. The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.
[8] B. Spiegelman,et al. IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.
[9] Yukiko Kurihara,et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.
[10] P. Godowski,et al. Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation , 1997, Oncogene.
[11] Pier Paolo Pandolfi,et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies , 1998, Nature Genetics.
[12] Stefan Grimm,et al. The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal , 1998 .
[13] S. Hazen,et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.
[14] A. Barclay,et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. , 2000, Immunity.
[15] M. Serra,et al. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. , 2000, Journal of hepatology.
[16] H. Adami,et al. Infections as a major preventable cause of human cancer , 2000, Journal of internal medicine.
[17] B. Blom,et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). , 2000, Science.
[18] S. Albani,et al. T cell repertoire formation and molecular mimicry in rheumatoid arthritis. , 2001, Current directions in autoimmunity.
[19] C. Benoist,et al. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? , 2001, Nature Immunology.
[20] R. Locksley,et al. The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.
[21] M. Karin,et al. Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.
[22] Qingxian Lu,et al. Homeostatic Regulation of the Immune System by Receptor Tyrosine Kinases of the Tyro 3 Family , 2001, Science.
[23] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[24] Ira Mellman,et al. Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.
[25] Judy H. Cho,et al. [Letters to Nature] , 1975, Nature.
[26] V. Fadok,et al. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. , 2001, The Journal of clinical investigation.
[27] Christopher K. Glass,et al. Atherosclerosis The Road Ahead , 2001, Cell.
[28] John Savill,et al. A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.
[29] M. Karin,et al. Missing Pieces in the NF-κB Puzzle , 2002, Cell.
[30] Carsten J. Kirschning,et al. HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal Pathway* , 2002, The Journal of Biological Chemistry.
[31] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[32] J. Lamb,et al. Inhibitory Effects of Apoptotic Cell Ingestion upon Endotoxin-Driven Myeloid Dendritic Cell Maturation1 , 2002, The Journal of Immunology.
[33] J. Charles Jennette,et al. Delayed Apoptotic Cell Clearance and Lupus-like Autoimmunity in Mice Lacking the c-mer Membrane Tyrosine Kinase , 2002, The Journal of experimental medicine.
[34] Siamon Gordon,et al. Pattern Recognition Receptors Doubling Up for the Innate Immune Response , 2002, Cell.
[35] M. Shlomchik,et al. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.
[36] Michael Karin,et al. A central role for JNK in obesity and insulin resistance , 2002, Nature.
[37] T. Mak,et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 , 2002, Nature.
[38] G. Cooke,et al. Toll-like receptor 4 polymorphisms and atherogenesis. , 2002, The New England journal of medicine.
[39] Massimo Gadina,et al. Cytokine Signaling in 2002 New Surprises in the Jak/Stat Pathway , 2002, Cell.
[40] Kyu-Jin Park,et al. Hepatitis C Virus NS5A Protein Modulates c-Jun N-terminal Kinase through Interaction with Tumor Necrosis Factor Receptor-associated Factor 2* , 2003, Journal of Biological Chemistry.
[41] S. Michalek,et al. Role of the Phosphatidylinositol 3 Kinase-Akt Pathway in the Regulation of IL-10 and IL-12 by Porphyromonas gingivalis Lipopolysaccharide1 , 2003, The Journal of Immunology.
[42] D. Gladman,et al. CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. , 2003, American journal of human genetics.
[43] H. Yoshida,et al. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation , 2003, Nature Immunology.
[44] Shizuo Akira,et al. Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2 , 2003, The Journal of experimental medicine.
[45] E. Wagner,et al. c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. , 2003, Developmental cell.
[46] P. Hawkins,et al. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. , 2003, The New England journal of medicine.
[47] M. Feldmann,et al. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. , 2003, Nature medicine.
[48] P. Murray,et al. Role of Nod2 in the Response of Macrophages to Toll-Like Receptor Agonists , 2003, Molecular and Cellular Biology.
[49] B. Neel,et al. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. , 2003, Trends in biochemical sciences.
[50] J. Fox,et al. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. , 2003, Cancer research.
[51] C. Haslett,et al. Cell biology. Eat me or die. , 2003, Science.
[52] P. Allavena,et al. Cross-Linking of the Mannose Receptor on Monocyte-Derived Dendritic Cells Activates an Anti-Inflammatory Immunosuppressive Program 1 , 2003, The Journal of Immunology.
[53] M. Karin,et al. IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα , 2003 .
[54] C. Haslett,et al. Eat Me or Die , 2003, Science.
[55] T. Maniatis,et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway , 2003, Nature Immunology.
[56] Shizuo Akira,et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.
[57] M. Karin,et al. The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .
[58] Adriano G. Rossi,et al. Inflammatory Resolution: new opportunities for drug discovery , 2004, Nature Reviews Drug Discovery.
[59] S. Gordon,et al. The Class A Macrophage Scavenger Receptor Attenuates CXC Chemokine Production and the Early Infiltration of Neutrophils in Sterile Peritonitis1 , 2004, The Journal of Immunology.
[60] S. Akira,et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[61] F. Nestle,et al. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. , 2004, The Journal of clinical investigation.
[62] J. Ioannidis,et al. Differential Effects of NOD2 Variants on Crohn's Disease Risk and Phenotype in Diverse Populations: A Metaanalysis , 2004, The American Journal of Gastroenterology.
[63] Stefan Wirtz,et al. TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling , 2004 .
[64] L. Glimcher,et al. Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.
[65] J. Tschopp,et al. Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. , 2004, Immunity.
[66] Xiaojing Ma,et al. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. , 2004, Immunity.
[67] James R. Goldenring,et al. Gastric Cancer Originating from Bone Marrow-Derived Cells , 2004, Science.
[68] W. Alexander,et al. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. , 2004, Annual review of immunology.
[69] Michael Karin,et al. IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.
[70] R. Sartor,et al. Treatment of inflammatory bowel disease with antibiotics. , 2004, Gastroenterology clinics of North America.
[71] F. Martinon,et al. Inflammatory Caspases Linking an Intracellular Innate Immune System to Autoinflammatory Diseases , 2004, Cell.
[72] Matthew T Wheeler,et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.
[73] C. D. Krause,et al. Interleukin-10 and related cytokines and receptors. , 2004, Annual review of immunology.
[74] M. Ray,et al. Macrophage-Stimulating Protein, the Ligand for the Stem Cell-Derived Tyrosine Kinase/RON Receptor Tyrosine Kinase, Inhibits IL-12 Production by Primary Peritoneal Macrophages Stimulated with IFN-γ and Lipopolysaccharide1 , 2004, The Journal of Immunology.
[75] A. Steere,et al. Elucidation of Lyme arthritis , 2004, Nature Reviews Immunology.
[76] S. Akira,et al. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus , 2005, The Journal of experimental medicine.
[77] A. Hoffmann,et al. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators. , 2005, Immunity.
[78] M. Chamaillard,et al. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. , 2005, Annual review of biochemistry.
[79] Michael Karin,et al. IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.
[80] Michael Karin,et al. Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing , 2005, Science.
[81] A. Hevener,et al. IKK-β links inflammation to obesity-induced insulin resistance , 2005, Nature Medicine.
[82] M. Karin,et al. NOD2 and Crohn's disease: loss or gain of function? , 2005, Immunity.
[83] H. Grönberg,et al. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. , 2005, Journal of the National Cancer Institute.
[84] Richard A. Flavell,et al. Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.
[85] Toby Lawrence,et al. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation , 2005, Nature.
[86] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[87] L. Steinman,et al. Design of effective immunotherapy for human autoimmunity , 2005, Nature.
[88] Jiahuai Han,et al. Activation and signaling of the p38 MAP kinase pathway , 2005, Cell Research.
[89] J. Rioux,et al. Paths to understanding the genetic basis of autoimmune disease , 2005, Nature.
[90] E. Wagner,et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins , 2005, Nature.
[91] S. Akira,et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus , 2005, The Journal of experimental medicine.
[92] Michael Karin,et al. Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases , 2005, Cell.
[93] M. Kretzler,et al. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. , 2005, Journal of the American Society of Nephrology : JASN.
[94] M. Karin,et al. From JNK to Pay Dirt: Jun Kinases, their Biochemistry, Physiology and Clinical Importance , 2005, IUBMB life.
[95] Michael Karin,et al. NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.
[96] D. Baltimore,et al. Achieving Stability of Lipopolysaccharide-Induced NF-κB Activation , 2005, Science.
[97] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[98] L. Pasquier,et al. Orphanet Journal of Rare Diseases , 2006 .
[99] M. Mann,et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 , 2006, Nature.
[100] C. Coban,et al. A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA , 2006, Nature Immunology.
[101] J. Hiscott,et al. MasterCARD: a priceless link to innate immunity. , 2006, Trends in molecular medicine.
[102] Bali Pulendran,et al. Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development , 2006, Cell.